Synovial fluid interleukin-8 and neutrophil function in rheumatoid arthritis and seronegative polyarthritis

British Journal of Rheumatology

Volumn 35, Issue 12, 1996, Pages 1244-1251

  Troughton, P R ^a,c   Platt, R ^a   Bird, H ^a   El Manzalawi, E ^b   Bassiouni, M ^b   Wright, V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b AL AZHAR UNIVERSITY   (Egypt)

^c CHAPEL ALLERTON HOSPITAL   (United Kingdom)

Author keywords

Cytidine deaminase; Interleukin 8; Neutrophil function; Polyarthritis; Rheumatoid arthritis; Synovial fluid

Indexed keywords

C REACTIVE PROTEIN; CYTIDINE DEAMINASE; GLUCOSE; INTERLEUKIN 8; LACTIC ACID;

ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KNEE; MALE; METABOLISM; NEUTROPHIL; PLASMA VISCOSITY; POLYARTHRITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID;

ADULT; AGED; ANTIBODIES; ARTHRITIS; ARTHRITIS, RHEUMATOID; C-REACTIVE PROTEIN; CYTIDINE DEAMINASE; DNA; FEMALE; GLYCOLYSIS; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; NEUTROPHILS; SYNOVIAL FLUID;

EID: 0030481566     PISSN: 02637103     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Baggiolini M, Dewald B, Moser B. Interleukin-8 and related chemotactic cytokines CXC and CC chemokines. Adv Immunol 1994;55:97-179.
2. Stricter RM, Koch AE, Antony VB, Pick RB Jr, Standiford TJ, Kunkel SL. The immunopathology of chemotactic cytokines: The role of interleukin-8 and monocyte chemoattractant protein-1. J Lab Clin Med 1994;123:183-97.
3. Huber AR, Kunkel SL, Todd RF III, Weiss SJ. Regulation of transendothelial neutrophil migration by endogenous interleukin-8. Science 1991;254:99-102.
4. Roberts PJ, Pizzey AR, Khwaja A, Carver JE, Mire-Sluis AR, Linch DC. The effects of IL-1 on neutrophil f-Met-Leu-Phe receptors, CD11b expression and metabolic activity, in comparison and combination with other cytokines. Br J Haematol 1993;84:586-94.
5. Smart SJ, Casale TB. TNF-α-induced transendothelial neutrophil migration is IL-8 dependent. Am J Physiol 1994;266:L238-45.
6. 2 activation in human neutrophils. Immunology 1992;75:157-63.
7. Seitz M, Dewald B, Gerber N, Baggiolini M. Enhanced production of neutrophil-activating peptide-1/interleukin-8 in rheumatoid arthritis. J Clin Invest 1991;87:463-9.
8. Seitz M, Dewald B, Ceska M, Gerber N, Baggiolini M. Interleukin-8 in inflammatory rheumatic diseases: synovial fluid levels, relation to rheumatoid factors, production by mononuclear cells, and effects of gold sodium thiomalate and methotrexate. Rheumatol Int 1992;12:159-64.
9. Symons JA, Wong WL, Palladino MA, Duff GW. Interleukin 8 in rheumatoid and osteoarthritis. Scand J Rheumatol 1992;21:92-4.
10. Peichl P, Ceska M, Effenberger F, Haberhauer G, Broell H, Lindley IJD. Presence of NAP/IL-8 in synovial fluids indicates a possible pathogenic role in rheumatoid arthritis. Scand J Immunol 1991;34:333-9.
11. Verburgh CA, Hart MHL, Aarden LA, Swaak AJG. Interleukin-8 (IL-8) in synovial fluid of rheumatoid and non-rheumatoid joint effusions. Clin Rheumatol 1993;12:494-9.
12. Van den Brink HR, van Wijk MJG, Geertzen RGM, Bijlsma JWJ. Influence of corticosteroid pulse therapy on the serum levels of soluble interleukin 2 receptor, interleukin 6 and interleukin 8 in patients with rheumatoid arthritis. J Rheumatol 1994;21:430-4.
13. Beaulieu AD, McCall SR. Differential expression of two major cytokines produced by neutrophils, interleukin-8 and the interleukin-1 receptor antagonists, in neutrophils isolated from the synovial fluid and peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum 1994;37:855-9.
14. Jones DD, Roberts EL. Enzymes of DNA metabolism in clinical diagnosis. Cambridge: Chancery Press, 1984.
15. Thompson PW, Jones DD, Currey HLF. Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis. Ann Rheum Dis 1986;45:9-14.
16. Skeith KJ, Wefuan J, Oswald R, Davis P. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus. J Rheumatol 1993;20:1309-15.
17. Helliwell PS, Marchesoni A, Peters M, Platt R, Wright V. Cytidine deaminase activity, C-reactive protein, histidine, and erythrocyte sedimentation rate as measures of disease activity in psoriatic arthritis. Ann Rheum Dis 1991;50:362-5.
18. Merry P, Grootveld M, Lunec J, Blake DR. Oxidative damage to lipids within the inflamed human joint provides evidence of radical-mediated hypoxic-reperfusion injury. Am J Clin Nutr 1991;53:362S-9S.
19. Lunec J, Halloran SP, White AG, Dormandy TL. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981;8:233-45.
20. Brennan EM, Zachariae COC, Chantry D et al. Detection of interleukin 8 biological activity in synovial fluid from patients with rheumatoid arthritis and the production of interleukin 8 mRNA by isolated synovial cells. Eur J Immunol 1990;20:2141-4.
21. Peichl P, Ceska M, Broell H, Effenberger F, Lindley IJD. Human neutrophil activating peptide/interleukin 8 acts as an autoantigen in rheumatoid arthritis. Ann Rheum Dis 1992;51:19-22.
22. Koch AE, Kunkel SL, Burrows JC et al. Synovial tissue macrophage as a source of the chemotactic cytokine IL-8. J Immunol 1991;147:2187-95.
23. Darbonne WC, Rice GC, Mohler MA et al. Red blood cells are a sink for interleukin-8, a leukocyte chemotaxin. J Clin Invest 1991;88:1362-9.
24. Tilg H, Shapiro L, Atkins MB, Dinarello CA, Mier JW. Induction of circulating and erythrocyte-bound IL-8 by IL-2 immunotherapy and suppression of its in vitro production by IL-1 receptor antagonist and soluble tumor necrosis factor receptor (p75) chimera. J Immunol 1993;151:3299-307.
25. Sylvester I, Yoshimura T, Sticherling M et al. Neutrophil attractant protein-1-immunoglobulin G immune complexes and free anti-NAP-1 antibody in normal human serum. J Clin Invest 1992;90:471-81.
26. Nurcombe HL, Bucknall RC, Edwards SW. Neutrophils isolated from the synovial fluid of patients with rheumatoid arthritis: priming and activation in-vivo. Ann Rheum Dis 1991;50:147-53.
27. Mansson B, Geborek P, Saxne T, Bjornsson S. Cytidine deaminase in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin acidosis, and cartilage proteoglycan release. Ann Rheum Dis 1990;49:594-7.
28. Moore AR, Iwamura H, Larbre JP, Scott DL, Willoughby DA. Cartilage degradation by polymorphonuclear leucocytes: in vitro assessment of the pathogenic mechanisms. Ann Rheum Dis 1993;52:27-31.
29. James MJ, Cleland LG, Rofe AM, Leslie AL. Intraarticular pressure and the relationship between synovial perfusion and metabolic demand. J Rheumatol 1990;174:521-7.
30. Edwards SW, Hallet MB, Campbell AK. Oxygen radical production may be limited by oxygen concentration. Biochem J 1984;217:851-4.
31. Currey HLF, Vernon-Roberts B. Examination of synovial fluid. Clin Rheum Dis 1976;2:149-77.
32. Davies EV, Williams BD, Campbell AK. Synovial fluid polymorphonuclear leucocytes from patients with rheumatoid arthritis have reduced MPO and NADPH-oxidase activity. Br J Rheumatol 1990;29:415-21.
33. Edwards SW, Hughes V, Barlow J, Bucknall R. Immunological detection of myeloperoxidase in synovial fluid from patients with rheumatoid arthritis. Biochem J 1988;250:81-5.
34. Savill J. Apoptosis: From worm to wonder drug? Br J Rheumatol 1995;34:95-8.
35. Woodruff T, Blake DR, Freeman J, Andrews FJ, Salt P, Lunec J. Is chronic synovitis an example of reperfusion injury? Ann Rheum Dis 1986;45:608-11.
36. Blake DR, Merry P, Unsworth J et al. Hypoxic-reperfusion injury in the inflamed human joint. Lancet 1989;i:289-92.